Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AorTech shares marked down for seeking $92 million

This article was originally published in Clinica

Executive Summary

AorTech International, a development-stage company which just two weeks ago secured a major deal with Jomed to use its Elasteon as a stent coating, took a beating at the hands of the UK investment community. The shares were marked down when it announced it was going to the market to seek a further £64 million ($92 million) in a share offering.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel